首页>Seminars in Thrombosis and Hemostasis>Inhibitor development in previously untreated patients with hemophilia A: a prospective long-term follow-up comparing plasma-derived and recombinant products.
Inhibitor development in previously untreated patients with hemophilia A: a prospective long-term follow-up comparing plasma-derived and recombinant products.
作者单位：The Centre of Pediatrics III, Department of Hematology and Oncology, Johann-Wolfgang-Goethe-University Hospital, Frankfurt am Main and the Institute of Human Genetics (J. Oldenburg) University, Wurzburg, Germany. carmen.escuriola@kgu.de[1]
换一批
